Clinical Study Results: AMNIOX CLARIX FLO and CLARIX CORD in Foot and Ankle Procedures

By Julie A. Vetalice

Study results suggest that AMNIOX Medical's CLARIX®  FLO and CLARIX® CORD 1K regenerative therapies, processed from umbilical cord and amniotic membrane utilizing CryoTek technology, improved outcomes in plantar fasciitis treatment and tarsal coalition repair.

Plantar Fasciitis Treatment with Particulate Human Amniotic Membrane comprised 60 patients treated with injections of CLARIX FLO particulate umbilical cord and amniotic membrane. Interim review at 18 weeks demonstrated that all treatments showed statistically significant reduction of foot pain as well as an increase in movment for daily living and sports participation.

The Use of Cryo-Preserved Umbilical Cord Plus Amniotic Membrane Tissue in the Resection of Tarsal Coalition offered retrospective review of 14 patients receiving the CLARIX CORD 1K matrix as an interpositional graft during tarsal coalition surgery. (Tarsal coalition is an abnormal connection of two or more bones in the foot.) Findings demonstrated a median 89.5% improvement in pain with improved range of motion and no infection or wound complications.

We first noticed AMNIOX in our 2011 NASS preview.

Sources: Amniox Medical, Inc.; ORTHOWORLD Inc.

Product Labels: Orthobiologic Soft Tissue Repair

Tags: Trial/Study